Benefit and safety analysis of dual antiplatelet drugs combined with high-dose atorvastatin or fluvastatin in patients with acute coronary syndrome undergoing direct percutaneous coronary intervention

LI Guo-song; WEI Zhi-ping; GUO Yi-li; WANG Zhi-jian; CHEN Sai-yong

doi:10.3969/j.issn.1672-8157.2021.04.002

Home>Articles>Benefit and safety analysis of dual antiplatelet drugs combined with high-dose atorvastatin or fluvastatin in patients with acute coronary syndrome undergoing direct percutaneous coronary intervention

DOI: 10.3969/j.issn.1672-8157.2021.04.002

Benefit and safety analysis of dual antiplatelet drugs combined with high-dose atorvastatin or fluvastatin in patients with acute coronary syndrome undergoing direct percutaneous coronary intervention

LI Guo-song

WEI Zhi-ping

GUO Yi-li

WANG Zhi-jian

CHEN Sai-yong

Machine-generated Keywords：

Publication Date：2021-08-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 216-219 )

Chinese Journal of Drug Application and Monitoring

ISTIC

ISSN：1672-8157

Year, Vol.(Issue)：2021,18(4)